#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1794438	B	PUBCHEM_BIOASSAY: Counterscreen for inhibitors of TLR9-MyD88 binding: fluorescence-based cell-based high throughput dose response assay to identify non-selective inhibitors of the beta-lactamase enzyme (BLA). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504734, AID504750, AID540250, AID540251]		235		cell-based format	PubChem BioAssays
2.	ALA1614376	B	PubChem BioAssay. FRET-based counterscreen for selective VIM-2 inhibitors: dose response biochemical high throughput screening assay to identify epi-absorbance assay artifacts. (Class of assay: confirmatory)	Pseudomonas aeruginosa	123		single protein format	PubChem BioAssays
3.	ALA1613916	B	PubChem BioAssay. Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase. (Class of assay: confirmatory)	Pseudomonas aeruginosa	93		single protein format	PubChem BioAssays
4.	ALA1614210	B	PubChem BioAssay. Epi-absorbance-based dose response biochemical high throughput screening assay for selective inhibitors of VIM-2 metallo-beta-lactamase. (Class of assay: confirmatory)	Pseudomonas aeruginosa	123		single protein format	PubChem BioAssays
5.	ALA1737906	U	PubChem BioAssay. Late stage results from the probe development efforts to identify selective inhibitors of VIM-2 metallo-beta-lactamase: probe results. (Class of assay: other) Panel member name: VIM-2 Ki Assay		1		assay format	PubChem BioAssays
6.	ALA1737908	U	PubChem BioAssay. Late stage results from the probe development efforts to identify selective inhibitors of VIM-2 metallo-beta-lactamase: probe results. (Class of assay: other) Panel member name: Nitrocefin-based IMP1 Inhibition Counterscreen		1		assay format	PubChem BioAssays
7.	ALA1737909	U	PubChem BioAssay. Late stage results from the probe development efforts to identify selective inhibitors of VIM-2 metallo-beta-lactamase: probe results. (Class of assay: other) Panel member name: Nitrocefin-based VIM2 Inhibition Assay		1		assay format	PubChem BioAssays
8.	ALA1737945	F	PubChem BioAssay. Late stage assay provider results from the probe development efforts to identify selective inhibitors of VIM-2 metallo-beta-lactamase: VIM-2-transformed E. coli growth inhibition in the presence of imipenem (synergy). (Class of assay: confirmatory)	Pseudomonas aeruginosa	1		assay format	PubChem BioAssays
9.	ALA1738439	U	PubChem BioAssay. Late stage results from the probe development efforts to identify selective inhibitors of VIM-2 metallo-beta-lactamase: Prior art results. (Class of assay: screening) Panel member name: Nitrocefin-based VIM2 Inhibition Assay		1		assay format	PubChem BioAssays
10.	ALA1738440	U	PubChem BioAssay. Late stage results from the probe development efforts to identify selective inhibitors of VIM-2 metallo-beta-lactamase: Prior art results. (Class of assay: screening) Panel member name: Nitrocefin-based IMP1 Inhibition Counterscreen		1		assay format	PubChem BioAssays
11.	ALA1738441	U	PubChem BioAssay. Late stage results from the probe development efforts to identify selective inhibitors of VIM-2 metallo-beta-lactamase: Prior art results. (Class of assay: screening) Panel member name: VIM-2 Ki Assay		1		assay format	PubChem BioAssays
12.	ALA2114720	F	PubChem BioAssay. Late stage counterscreen results from the probe development effort to identify common IMP-1 and VIM-2 inhibitors: Epi-absorbance-based biochemical dose response assay for inhibitors of TEM-1 metallo-beta-lactamase. (Class of assay: confirmatory)	Pseudomonas aeruginosa	6		assay format	PubChem BioAssays
13.	ALA2114772	F	PubChem BioAssay. Counterscreen for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and receptor-interacting serine-threonine kinase 2 (RIPK2): Fluorescence-based cell-based high throughput dose response assay to identify non-selective inhibitors of the beta-lactamase enzyme (BLA). (Class of assay: confirmatory)	Pseudomonas aeruginosa	232		cell-based format	PubChem BioAssays